2 news items
Innoviva Reports First Quarter 2024 Financial Results; Highlights Recent Company Progress
INVA
8 May 24
and the investigational zoliflodacin currently being developed for the treatment of uncomplicated gonorrhea, and La Jolla Pharmaceutical Company, including
Innoviva to Participate in the BofA Securities Health Care Conference
INVA
8 May 24
and the investigational zoliflodacin currently being developed for the treatment of uncomplicated gonorrhea, and La Jolla Pharmaceutical Company, including GIAPREZA
- Prev
- 1
- Next